Youth-onset type 2 diabetes: translating epidemiology into clinical trials Laura PyleMegan M. Kelsey Review 01 June 2021 Pages: 1709 - 1716
A UK nationwide study of people with type 1 diabetes admitted to hospital with COVID-19 infection Yue RuanRobert E. J. Ryderon behalf of the ABCD Covid-19 audit group Article Open access 08 May 2021 Pages: 1717 - 1724
Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin Laura J. ReidFraser W. GibbShareen Forbes Article Open access 08 May 2021 Pages: 1725 - 1736
Acute hyperglycaemia does not have a consistent adverse effect on exercise performance in recreationally active young people with type 1 diabetes: a randomised crossover in-clinic study Karen M. RothackerSam ArmstrongElizabeth A. Davis Article 04 May 2021 Pages: 1737 - 1748
Markers of metabolic health and gut microbiome diversity: findings from two population-based cohort studies Semi ZouiouichErikka LoftfieldMarc J. Gunter Article Open access 10 June 2021 Pages: 1749 - 1759
Long-term metformin use and risk of pneumonia and related death in type 2 diabetes: a registry-based cohort study Aimin YangMai ShiElaine Chow Short Communication 12 April 2021 Pages: 1760 - 1765
Early-life exposure to the Chinese famine, genetic susceptibility and the risk of type 2 diabetes in adulthood Bin WangJing ChengYingli Lu Article 22 April 2021 Pages: 1766 - 1774
Comparison of the contributions of impaired beta cell function and insulin resistance to the development of type 2 diabetes in a Japanese community: the Hisayama Study Masahito YoshinariYoichiro HirakawaToshiharu Ninomiya Article 28 April 2021 Pages: 1775 - 1784
The oxylipin profile is associated with development of type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY) Teresa BucknerLauren A. VanderlindenJill M. Norris Article 24 April 2021 Pages: 1785 - 1794
Physical activity attenuates postprandial hyperglycaemia in homozygous TBC1D4 loss-of-function mutation carriers Theresia M. SchnurrEmil JørsboeTorben Hansen Article Open access 29 April 2021 Pages: 1795 - 1804
Genetic predisposition in the 2′-5′A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity Kristina PedersenMartin Haupt-JorgensenKarsten Buschard Article Open access 11 May 2021 Pages: 1805 - 1815
Reduced beta cell number rather than size is a major contributor to beta cell loss in type 2 diabetes Hironobu SasakiYoshifumi SaishoHiroshi Itoh Short Communication Open access 03 May 2021 Pages: 1816 - 1821
Peripheral immune circadian variation, synchronisation and possible dysrhythmia in established type 1 diabetes Craig A. BeamEleni BeliLinda A. DiMeglio Article Open access 18 May 2021 Pages: 1822 - 1833
Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus Christina KohlmorgenStephen GerferMaria Grandoch Article Open access 16 June 2021 Pages: 1834 - 1849
HAND2 is a novel obesity-linked adipogenic transcription factor regulated by glucocorticoid signalling Maude GiroudFoivos-Filippos TsokanosStephan Herzig Article Open access 20 May 2021 Pages: 1850 - 1865
Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo Sonja LindforsZydrune Polianskyte-PrauseSanna Lehtonen Article Open access 14 May 2021 Pages: 1866 - 1879
Greater daily glucose variability and lower time in range assessed with continuous glucose monitoring are associated with greater aortic stiffness: The Maastricht Study Yuri D. ForemanWilliam P. T. M. van DoornCoen D. A. Stehouwer Article Open access 15 May 2021 Pages: 1880 - 1892
Does nocturnal hypoglycaemia really improve quality of life? Uffe SøholmMelanie M. BroadleyFrans Pouwer Letter 20 May 2021 Pages: 1893 - 1894
Does nocturnal hypoglycaemia really improve quality of life? Reply to Søholm U, Broadley MM, Choudhary P et al [letter] Marie M. HenriksenHenrik U. AndersenUlrik Pedersen-Bjergaard Letter 17 June 2021 Pages: 1895 - 1896
ADHD should be considered in adolescents with type 1 diabetes and poor metabolic control Charlotte NylanderElisabeth Fernell Letter 09 June 2021 Pages: 1897 - 1898
Correction to: Acute hyperglycaemia does not have a consistent adverse effect on exercise performance in recreationally active young people with type 1 diabetes: a randomised crossover in-clinic study Karen M. RothackerSam ArmstrongElizabeth A. Davis Correction 11 June 2021 Pages: 1899 - 1899
Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study Linong JiYing DuLei Chen Correction Open access 26 May 2021 Pages: 1900 - 1901